ACE2 and COVID-19: Moreover, increasing evidence suggests the role of the SARS-CoV-2 spike protein and its interaction with the angiotensin-converting enzyme (ACE2) in the pathogenesis of myocarditis post mRNA COVID-19 vaccination [51,52].